Researchers at the University of Southern California have identified experimental compounds that could help reduce the brain inflammation associated with Alzheimer's disease. The findings, published in the Nature journal npj Drug Discovery, focus on an enzyme called calcium-dependent phospholipase A2, or cPLA2, which appears to play an important role in inflammation inside the brain.
The USC team linked elevated cPLA2 activity to Alzheimer's risk whil...

3 weeks ago
38








English (US) ·